| Tomlinson, A.C.A.; Chen, A.; Knox, J.E.; Yano, J.K. (2024). Tricomplex of RMC-7977, KRAS G12A, and CypA. Protein Data Bank: 8tbj. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Chen, A.; Knox, J.E.; Yano, J.K. (2024). Tricomplex of RMC-7977, NRAS WT, and CypA. Protein Data Bank: 8tbi. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Chen, A.; Knox, J.E.; Yano, J.K. (2024). Tricomplex of RMC-7977, KRAS WT, and CypA. Protein Data Bank: 8tbf. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Knox, J.E.; Yano, J.K. (2025). Tri-complex of Compound-4, KRAS G12C, and CypA. Protein Data Bank: 9bfw. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Knox, J.E.; Yano, J.K. (2025). Tri-complex of Compound-19, KRAS G12C, and CypA. Protein Data Bank: 9bfv. |
CMCF-ID |
PDB Deposition |
Health |
| Tomlinson, A.C.A.; Saldajeno-Concar, M.; Chen, A.; Knox, J.E.; Yano, J.K. et al. (2025). Tri-complex of Daraxonrasib (RMC-6236), KRAS G12V, and CypA. Protein Data Bank: 9bg6. |
CMCF-ID |
PDB Deposition |
Health |
| Toure, Momar; Johnson, Theresa; Li, Bin; Schmidt, Ralf; Ma, Hong et al. (2023). Discovery of quinazoline HPK1 inhibitors with high cellular potency. Bioorganic and Medicinal Chemistry 92, 117423. 10.1016/j.bmc.2023.117423. [PDB: 8cij] |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Tran, N.; Holyoak, T. (2025). Crystal Structure of the Gemella haemolysans Immunoglobulin A1 Protease Trypsin-Like Domain. Protein Data Bank: 9ect. |
CMCF-BM |
PDB Deposition |
Health |
| Tran, Norman; Redzic, Jasmina S.; Eisenmesser, Elan Z.; Holyoak, Todd (2025). The structure of the Gemella haemolysans M26 IgA1 protease trypsin-like domain. Acta Crystallographica Section F:Structural Biology Communications 81(4) . 10.1107/s2053230x25001219. [PDB: 9ect] |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Trofimova, D.; Doubleday, C.; Hunter, B.; Serrano Arevalo, J.; Davison, E. et al. (2024). Crystal structure of the Candida albicans kinesin-8 proximal tail domain. Protein Data Bank: 9crw. |
CMCF-ID |
PDB Deposition |
Health |
| Vallée, Frédéric; Casás-Selves, Matias; Bubenik, Monica; Duplessis, Martin; Sow, Boubacar et al. (2025). Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.5c00529. [PDB: 9o63] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Varkaris, Andreas; Pazolli, Ermira; Gunaydin, Hakan; Wang, Qi; Pierce, Levi et al. (2023). Discovery and clinical proof-of-concept of RLY-2608, a first-in-class mutant-selective allosteric PI3Ka inhibitor that decouples anti-tumor activity from hyperinsulinemia. Cancer Discovery . 10.1158/2159-8290.cd-23-0944. [PDB: 8ts7] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Veyron, S.; Cummer, R. (2024). C. difficile Tcdb cysteine protease domain in complex with IP6. Protein Data Bank: 9bja. |
CMCF-ID |
PDB Deposition |
Health |
| Vu, Binh T.; Dominique, Romyr; Fahr, Bruce J.; Li, Hongju H.; Fry, David C. et al. (2024). Discovery of Rezatapopt (PC14586), a First-in-Class, Small-Molecule Reactivator of p53 Y220C Mutant in Development. ACS Medicinal Chemistry Letters . 10.1021/acsmedchemlett.4c00379. [PDB: 9br4] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Walker, Morgan E.; Zhu, Wei; Peterson, Janine H.; Wang, Hao; Patteson, Jon et al. (2025). Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibition. Nature Communications 16(1) . 10.1038/s41467-025-58086-w. [PDB: 9cs0, 9cs1] |
CMCF-ID |
Peer-Reviewed Article |
Health |